An antagonist mutant IL-15/Fc promotes transplant tolerance

Transplantation

Volumn 81, Issue 1, 2006, Pages 109-116

  Xin, Xiao Zheng ^a   Gao, Wei ^b   Donskoy, Elina ^b   Neuberg, Manfred ^b   Ruediger, Manfred ^b   Strom, Terry B ^a,c   Moll, Thomas ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Cardion AG   (Germany)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Cytokines; Heart; Islet; Rejection; Transplantation

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; CYTOKINE; HYBRID PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G2A; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CARDIAC GRAFT REJECTION; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOCHEMISTRY; MALE; MINOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RECIPIENT; TREATMENT DURATION;

ANIMALS; ANTIBODIES; BIOLOGICAL MARKERS; CD40 LIGAND; CELL LINE; CRICETINAE; GENE EXPRESSION REGULATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS; IMMUNE TOLERANCE; IMMUNOGLOBULIN FC FRAGMENTS; INFLAMMATION; INTERLEUKIN-15; MACROPHAGES; MICE; MODELS, IMMUNOLOGICAL; MUTATION; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

EID: 31044445709     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000188139.11931.98     Document Type: Article

References (25)

1. Grabstein KH, Eisenman J, Shanebeck K, et al. Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Nature 1994; 264: 965.
2. Parrish-Novak J, Dillon SR, Nelson A, et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000; 408(6808): 57.
3. Alleva DG, Kaser SB, Monroy MA, et al. IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol 1997; 159(6): 2941.
4. Lodolce JP, Boone DL, Chai S, et al. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 1998; 9(5): 669.
5. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice [see comments]. J Exp Med 2000; 191 (5): 771.
6. Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in murine macrophages. J Immunol 1996; 156(2): 735.
7. Fehniger TA, Suzuki K, Ponnappan A, et al. Fatal Leukemia in Interleukin 15 Transgenic Mice Follows Early Expansions in Natural Killer and Memory Phenotype CD8(+) T Cells. J Exp Med 2001; 193(2): 219.
8. Carson WE. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of IL-2 receptor. J Exp Med 1994; 180: 1395.
9. Kanegane H, Tosato G. Activation of naive and memory T cells by interleukin-15. Blood 1996; 88(1): 230.
10. Bulfone-Paus S, Ungureanu D, Pohl T, et al. Interleukin-15 protets from lethal apoptosis in vivo. Nature Medicine 1997; 3: 1124.
11. Li XC, Demirci G, Ferrari-Lacraz S, et al. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat Med 2001; 7(1): 114.
12. Pavlakis M, Strehlau J, Lipman M, et al. Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 1996; 62 (4): 543.
13. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001; 97(1): 14.
14. Kim YS, Maslinski W, Zheng XX, et al. Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol 1998; 160(2): 5742.
15. Zheng XX, Steele AW, Hancock WW, et al. IL-2 receptor-targeted cytolytic IL-2/Fc fusion protein treatment blocks diabetogenic autoimmunity in nonobese diabetic mice. J Immunol 1999; 163(7): 4041.
16. Ferrari-Lacraz S, Zheng XX, Kim YS, et al. An antagonist IL-15/Fc protein prevents costimulation blockade-resistant rejection. J Immunol 2001; 167(6): 3478.
17. Zheng XX, Sanchez-Fueyo A, Sho M, et al. Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance. Immunity 2003; 19(4): 503.
18. Zheng XX, Steele AW, Hancock WW, et al. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice. J Immunol 1997; 158(9): 4507.
19. Corry RJ, Minn HJ, Russell PS. Primarily cascularized allograft of hearts in mice. The role of H-2D, H2-K and non-N-2 antigens in rejection. Transplantation 1973; 16: 343.
20. Zheng XX, Steele AW, Hancock WW, et al. A Non-cytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes surpressor phenomena in NOD mice. J Immunol 1997; 158: 4507.
21. Strehlau J, Pavlakis M, Lipman M, et al. Quantitative detection of immune activation transcripts as a diagonostic tool in kidney transplantation. Proc Natl Acad Sci USA 1997; 94: 695.
22. van Gelder T, Baan CC, Balk AH, et al. Blockade of the interleukin (IL)-2/IL-2 receptor pathway with a monoclonal anti-IL-2 receptor antibody (BT563) does not prevent the development of acute heart allograft rejection in humans. Transplantation 1998; 65(3): 405.
23. Baan CC, Knoop CJ, van Gelder T, et al. Anti-CD25 therapy reveals the redundancy of the intragraft cytokine network after clinical heart transplantation. Transplantation 1999; 67(6): 870.
24. Li XC, Strom TB, Turka LA, Wells AD. T cell death and transplantation tolerance. Immunity 2001; 14(4): 407.
25. Smith XG, Bolton EM, Ruchatz H, et al. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival. J Immunol 2000; 165(6): 3444.